The post Oracle and Ci4CC Collaborate to Enhance AI in Cancer Research appeared on BitcoinEthereumNews.com. Rongchai Wang Nov 07, 2025 11:54 Oracle Health and Ci4CC are collaborating to advance AI-driven oncology care and research, aiming to integrate clinical and genomic data for personalized medicine solutions. Oracle Health and Life Sciences has announced a strategic partnership with the Cancer Center Informatics Society (Ci4CC), a nonprofit organization that brings together cancer centers, researchers, and industry innovators. This collaboration is aimed at accelerating artificial intelligence (AI) innovation in oncology care and research, according to Oracle. Advancing Oncology Care The partnership will leverage Oracle’s advanced technological capabilities alongside Ci4CC’s Initiatives Program and its expansive network of National Cancer Institute (NCI)-Designated and Community Care Cancer Centers. Together, the organizations aim to design an electronic health record (EHR) system optimized specifically for cancer care. Seema Verma, Executive Vice President and General Manager of Oracle Health and Life Sciences, emphasized the importance of AI and data science in combating cancer, a leading cause of death worldwide. Verma noted that by combining Ci4CC’s expertise and network with Oracle’s AI-powered healthcare solutions, the collaboration could significantly accelerate discoveries that may contribute to curing cancer. Innovative Approaches in Clinical Research The collaboration seeks to foster initiatives across various facets of oncology care and clinical research. This includes the integration of clinical and genomic data to create personalized medicine solutions, development of AI-driven approaches for clinical trial innovation and drug development, and the establishment of comprehensive real-world evidence frameworks aimed at advancing precision oncology platforms. Sorena Nadaf-Rahrov, President & CEO of the Cancer Center Informatics Society, regards the alliance with Oracle as a pivotal moment for Ci4CC. Nadaf-Rahrov highlighted that advancements in cancer research and clinical care are best achieved through collaborative networks, which are central to Ci4CC’s mission. Data-Driven Health Innovations By integrating Oracle’s state-of-the-art AI technology… The post Oracle and Ci4CC Collaborate to Enhance AI in Cancer Research appeared on BitcoinEthereumNews.com. Rongchai Wang Nov 07, 2025 11:54 Oracle Health and Ci4CC are collaborating to advance AI-driven oncology care and research, aiming to integrate clinical and genomic data for personalized medicine solutions. Oracle Health and Life Sciences has announced a strategic partnership with the Cancer Center Informatics Society (Ci4CC), a nonprofit organization that brings together cancer centers, researchers, and industry innovators. This collaboration is aimed at accelerating artificial intelligence (AI) innovation in oncology care and research, according to Oracle. Advancing Oncology Care The partnership will leverage Oracle’s advanced technological capabilities alongside Ci4CC’s Initiatives Program and its expansive network of National Cancer Institute (NCI)-Designated and Community Care Cancer Centers. Together, the organizations aim to design an electronic health record (EHR) system optimized specifically for cancer care. Seema Verma, Executive Vice President and General Manager of Oracle Health and Life Sciences, emphasized the importance of AI and data science in combating cancer, a leading cause of death worldwide. Verma noted that by combining Ci4CC’s expertise and network with Oracle’s AI-powered healthcare solutions, the collaboration could significantly accelerate discoveries that may contribute to curing cancer. Innovative Approaches in Clinical Research The collaboration seeks to foster initiatives across various facets of oncology care and clinical research. This includes the integration of clinical and genomic data to create personalized medicine solutions, development of AI-driven approaches for clinical trial innovation and drug development, and the establishment of comprehensive real-world evidence frameworks aimed at advancing precision oncology platforms. Sorena Nadaf-Rahrov, President & CEO of the Cancer Center Informatics Society, regards the alliance with Oracle as a pivotal moment for Ci4CC. Nadaf-Rahrov highlighted that advancements in cancer research and clinical care are best achieved through collaborative networks, which are central to Ci4CC’s mission. Data-Driven Health Innovations By integrating Oracle’s state-of-the-art AI technology…

Oracle and Ci4CC Collaborate to Enhance AI in Cancer Research

2025/11/08 16:56


Rongchai Wang
Nov 07, 2025 11:54

Oracle Health and Ci4CC are collaborating to advance AI-driven oncology care and research, aiming to integrate clinical and genomic data for personalized medicine solutions.

Oracle Health and Life Sciences has announced a strategic partnership with the Cancer Center Informatics Society (Ci4CC), a nonprofit organization that brings together cancer centers, researchers, and industry innovators. This collaboration is aimed at accelerating artificial intelligence (AI) innovation in oncology care and research, according to Oracle.

Advancing Oncology Care

The partnership will leverage Oracle’s advanced technological capabilities alongside Ci4CC’s Initiatives Program and its expansive network of National Cancer Institute (NCI)-Designated and Community Care Cancer Centers. Together, the organizations aim to design an electronic health record (EHR) system optimized specifically for cancer care.

Seema Verma, Executive Vice President and General Manager of Oracle Health and Life Sciences, emphasized the importance of AI and data science in combating cancer, a leading cause of death worldwide. Verma noted that by combining Ci4CC’s expertise and network with Oracle’s AI-powered healthcare solutions, the collaboration could significantly accelerate discoveries that may contribute to curing cancer.

Innovative Approaches in Clinical Research

The collaboration seeks to foster initiatives across various facets of oncology care and clinical research. This includes the integration of clinical and genomic data to create personalized medicine solutions, development of AI-driven approaches for clinical trial innovation and drug development, and the establishment of comprehensive real-world evidence frameworks aimed at advancing precision oncology platforms.

Sorena Nadaf-Rahrov, President & CEO of the Cancer Center Informatics Society, regards the alliance with Oracle as a pivotal moment for Ci4CC. Nadaf-Rahrov highlighted that advancements in cancer research and clinical care are best achieved through collaborative networks, which are central to Ci4CC’s mission.

Data-Driven Health Innovations

By integrating Oracle’s state-of-the-art AI technology with real-world data from Ci4CC’s network of cancer centers, the collaboration aims to transform data into actionable knowledge that can redefine cancer research and improve patient care. This strategic partnership is part of a non-binding agreement, indicating a flexible yet committed approach to achieving their shared objectives.

Image source: Shutterstock

Source: https://blockchain.news/news/oracle-ci4cc-collaborate-enhance-ai-cancer-research

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Privacy Coins Rally Driven by Technicals, Narrative

Privacy Coins Rally Driven by Technicals, Narrative

The post Privacy Coins Rally Driven by Technicals, Narrative appeared on BitcoinEthereumNews.com. Privacy tokens are taking center stage this week, bucking the slump that has affected the broader cryptocurrency market. Notable commentators in the cryptocurrency space have been predicting a spike in privacy coin prices for months. Their projections now appear to be coming true. Some have wondered whether there hasn’t been a coordinated effort to pump privacy coin prices. Zcash Foundation’s executive director, Alex Bornstein, has told Cointelegraph that Zcash’s recent success is due to broader concerns about governments infringing on users’ right to privacy. A combination of hype and technicals has put privacy coins back in the spotlight as other coins struggle. Zcash Privacy coin Zcash (ZEC) has made impressive gains, with its market capitalization up more than 10% over the last week. Zcash’s price is up over 76% over the last seven days to $632. It flipped Monero (XMR) to become the largest privacy coin by market capitalization. Zcash price saw gains of over 75% on the week. Source: CoinMarketCap The price increase follows significant upgrades made by the network’s developer, the Electric Coin Company. At the beginning of the month, the company introduced cross-chain swaps and private payments by integrating with the transaction layer Near Intents. The integration resulted in a spike in Zcash volume on Near Intents and an expansion of the “shielded pool” — i.e., the collection of encrypted addresses where ZEC is stored. Bornstein told Cointelegraph on Chain Reaction that “there’s just a powerful narrative, and I think people are just waking up to what Zcash can really accomplish.” Related: Why Zcash and privacy tokens are back in the conversation Monero Monero (XMR), which until recently was the largest privacy coin on the market, saw a near 10% price gain over the past week. Its market capitalization increased 2.7% to $6.62 billion. Monero price closed…
Share
BitcoinEthereumNews2025/11/09 00:16